Cargando…
Development and external validation of a prediction model for the transition from mild to moderate or severe form of COVID-19
OBJECTIVES: COVID-19 pandemic seems to be under control. However, despite the vaccines, 5 to 10% of the patients with mild disease develop moderate to critical forms with potential lethal evolution. In addition to assess lung infection spread, chest CT helps to detect complications. Developing a pre...
Autores principales: | Zysman, Maéva, Asselineau, Julien, Saut, Olivier, Frison, Eric, Oranger, Mathilde, Maurac, Arnaud, Charriot, Jeremy, Achkir, Rkia, Regueme, Sophie, Klein, Emilie, Bommart, Sébastien, Bourdin, Arnaud, Dournes, Gael, Casteigt, Julien, Blum, Alain, Ferretti, Gilbert, Degano, Bruno, Thiébaut, Rodolphe, Chabot, Francois, Berger, Patrick, Laurent, Francois, Benlala, Ilyes |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10667132/ https://www.ncbi.nlm.nih.gov/pubmed/37405504 http://dx.doi.org/10.1007/s00330-023-09759-x |
Ejemplares similares
-
Développement et validation externe d’un modèle de prédiction du passage d’une forme légère à modérée ou sévère de COVID-19, à l’aide du scanner thoracique
por: Zysman, M., et al.
Publicado: (2023) -
Contrast-enhanced Magnetic Resonance Imaging Does Not Detect a Progression in Lung Morphological Score in Preschool Children with Cystic Fibrosis
por: Dournes, Gaël, et al.
Publicado: (2021) -
Assessing pulmonary hypertension in COPD. Is there a role for computed tomography?
por: Coste, Florence, et al.
Publicado: (2019) -
Sputum-Rheology-Based Strategy for Guiding Azithromycin Prescription in COPD Patients with Frequent Exacerbations: A Randomized, Controlled Study (“COPD CARhE”)
por: Charriot, Jeremy, et al.
Publicado: (2023) -
Calcul de taille d’étude pour le développement d’un modèle de prédiction d’une aggravation d’une forme légère de COVID-19
por: Asselineau, J., et al.
Publicado: (2021)